Inhibition of the Receptor Tyrosine Kinase ROR1 by Anti-ROR1 Monoclonal Antibodies and siRNA Induced Apoptosis of Melanoma Cells

The Onco-Embryonic Antigen ROR1 Is Expressed by a Variety of Human Cancers

(2012) Suping Zhang et al.   AMERICAN JOURNAL OF PATHOLOGY

NKX2-1/TITF1/TTF-1-Induced ROR1 Is Required to Sustain EGFR Survival Signaling in Lung Adenocarcinoma

(2012) Tomoya Yamaguchi et al.   CANCER CELL

Post-Translational Modifications of PTEN and their Potential Therapeutic Implications

(2012) G. Singh et al.   CURRENT CANCER DRUG TARGETS

Ror family receptor tyrosine kinases regulate the maintenance of neural progenitor cells in the developing neocortex

(2012) M. Endo et al.   JOURNAL OF CELL SCIENCE

Induction of IgM, IgA and IgE Antibodies in Colorectal Cancer Patients Vaccinated with a Recombinant CEA Protein

(2012) Caroline Staff et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells

(2012) A H Daneshmanesh et al.   LEUKEMIA

Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies

(2012) Amir Hossein Daneshmanesh et al.   LEUKEMIA & LYMPHOMA

ROR1 Is Expressed in Human Breast Cancer and Associated with Enhanced Tumor-Cell Growth

(2012) Suping Zhang et al.   PLoS One

Post-translational modifications regulate signalling by Ror1

(2011) M. Kaucká et al.   Acta Physiologica

Post-translational modifications of the extracellular matrix are key events in cancer progression: Opportunities for biochemical marker development

(2011) D. J. Leeming et al.   BIOMARKERS

A review of the mammalian unfolded protein response

(2011) Anirikh Chakrabarti et al.   BIOTECHNOLOGY AND BIOENGINEERING

Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis

(2011) A. Gentile et al.   CANCER RESEARCH

Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells

(2010) Aniruddha Choudhury et al.   BRITISH JOURNAL OF HAEMATOLOGY

A Tissue-Specific Atlas of Mouse Protein Phosphorylation and Expression

(2010) Edward L. Huttlin et al.   CELL

Asymmetric tyrosine kinase arrangements in activation or autophosphorylation of receptor tyrosine kinases

(2010) Jae Hyun Bae et al.   MOLECULES AND CELLS

HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank

(2009) Rosa Mendez et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia

(2009) Mohammad Hojjat-Farsangi et al.   CANCER SCIENCE

Entering a New Era of Rational Biomarker Discovery for Early Detection of Melanoma Metastases: Secretome Analysis of Associated Stroma Cells

(2009) Verena Paulitschke et al.   JOURNAL OF PROTEOME RESEARCH

Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy

(2008) Amir H. DaneshManesh et al.   INTERNATIONAL JOURNAL OF CANCER

CRAF Autophosphorylation of Serine 621 Is Required to Prevent Its Proteasome-Mediated Degradation

(2008) Catherine Noble et al.   MOLECULAR CELL

Ror receptor tyrosine kinases: orphans no more

(2008) Jennifer L. Green et al.   TRENDS IN CELL BIOLOGY